| . | MIDCABG 260 patients, % (n) . | DES 196 patients, % (n) . | P-value . |
|---|---|---|---|
| Mean age (years) | 63.4 ±12 | 62.4 ±12 | 0.3 |
| Hypertension | 57 (155) | 67 (131) | 0.1 |
| Diabetes | 21 (56) | 60 (117) | <0.0001 |
| Smoking habits | 54 (141) | 46 (90) | 0.1 |
| Family history | 47 (122) | 48 (95) | 0.8 |
| Hypercholesterolaemia | 71 (186) | 70 (137) | 0.7 |
| EF <30% | 3 (8) | 1 (3) | 0.7 |
| EF 30–50% | 12 (32) | 10 (19) | 0.4 |
| EF >50% | 85 (220) | 90 (174) | 0.2 |
| Mean EuroSCORE | 3.27 (range: 0–11) | 3.26 (range: 0–15) | 0.4 |
| Female gender | 25 (66) | 26 (52) | 0.9 |
| Unstable angina | 15 (40) | 21 (41) | 0.1 |
| PVD | 19 (50) | 13 (26) | 0.1 |
| COPD | 6 (17) | 5 (9) | 0.1 |
| Previous CABG | 0.4 (1) | 5 (10) | 0.001 |
| Recent (<3 months) MI | 12 (31) | 21 (42) | 0.01 |
| Renal failure | 0.8 (2) | 3 (7) | 0.07 |
| . | MIDCABG 260 patients, % (n) . | DES 196 patients, % (n) . | P-value . |
|---|---|---|---|
| Mean age (years) | 63.4 ±12 | 62.4 ±12 | 0.3 |
| Hypertension | 57 (155) | 67 (131) | 0.1 |
| Diabetes | 21 (56) | 60 (117) | <0.0001 |
| Smoking habits | 54 (141) | 46 (90) | 0.1 |
| Family history | 47 (122) | 48 (95) | 0.8 |
| Hypercholesterolaemia | 71 (186) | 70 (137) | 0.7 |
| EF <30% | 3 (8) | 1 (3) | 0.7 |
| EF 30–50% | 12 (32) | 10 (19) | 0.4 |
| EF >50% | 85 (220) | 90 (174) | 0.2 |
| Mean EuroSCORE | 3.27 (range: 0–11) | 3.26 (range: 0–15) | 0.4 |
| Female gender | 25 (66) | 26 (52) | 0.9 |
| Unstable angina | 15 (40) | 21 (41) | 0.1 |
| PVD | 19 (50) | 13 (26) | 0.1 |
| COPD | 6 (17) | 5 (9) | 0.1 |
| Previous CABG | 0.4 (1) | 5 (10) | 0.001 |
| Recent (<3 months) MI | 12 (31) | 21 (42) | 0.01 |
| Renal failure | 0.8 (2) | 3 (7) | 0.07 |
MIDCABG: minimally invasive coronary artery bypass grafting; DES: drug-eluding stents; PVD: peripheral vascular disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarct; EF: ejection fraction.
| . | MIDCABG 260 patients, % (n) . | DES 196 patients, % (n) . | P-value . |
|---|---|---|---|
| Mean age (years) | 63.4 ±12 | 62.4 ±12 | 0.3 |
| Hypertension | 57 (155) | 67 (131) | 0.1 |
| Diabetes | 21 (56) | 60 (117) | <0.0001 |
| Smoking habits | 54 (141) | 46 (90) | 0.1 |
| Family history | 47 (122) | 48 (95) | 0.8 |
| Hypercholesterolaemia | 71 (186) | 70 (137) | 0.7 |
| EF <30% | 3 (8) | 1 (3) | 0.7 |
| EF 30–50% | 12 (32) | 10 (19) | 0.4 |
| EF >50% | 85 (220) | 90 (174) | 0.2 |
| Mean EuroSCORE | 3.27 (range: 0–11) | 3.26 (range: 0–15) | 0.4 |
| Female gender | 25 (66) | 26 (52) | 0.9 |
| Unstable angina | 15 (40) | 21 (41) | 0.1 |
| PVD | 19 (50) | 13 (26) | 0.1 |
| COPD | 6 (17) | 5 (9) | 0.1 |
| Previous CABG | 0.4 (1) | 5 (10) | 0.001 |
| Recent (<3 months) MI | 12 (31) | 21 (42) | 0.01 |
| Renal failure | 0.8 (2) | 3 (7) | 0.07 |
| . | MIDCABG 260 patients, % (n) . | DES 196 patients, % (n) . | P-value . |
|---|---|---|---|
| Mean age (years) | 63.4 ±12 | 62.4 ±12 | 0.3 |
| Hypertension | 57 (155) | 67 (131) | 0.1 |
| Diabetes | 21 (56) | 60 (117) | <0.0001 |
| Smoking habits | 54 (141) | 46 (90) | 0.1 |
| Family history | 47 (122) | 48 (95) | 0.8 |
| Hypercholesterolaemia | 71 (186) | 70 (137) | 0.7 |
| EF <30% | 3 (8) | 1 (3) | 0.7 |
| EF 30–50% | 12 (32) | 10 (19) | 0.4 |
| EF >50% | 85 (220) | 90 (174) | 0.2 |
| Mean EuroSCORE | 3.27 (range: 0–11) | 3.26 (range: 0–15) | 0.4 |
| Female gender | 25 (66) | 26 (52) | 0.9 |
| Unstable angina | 15 (40) | 21 (41) | 0.1 |
| PVD | 19 (50) | 13 (26) | 0.1 |
| COPD | 6 (17) | 5 (9) | 0.1 |
| Previous CABG | 0.4 (1) | 5 (10) | 0.001 |
| Recent (<3 months) MI | 12 (31) | 21 (42) | 0.01 |
| Renal failure | 0.8 (2) | 3 (7) | 0.07 |
MIDCABG: minimally invasive coronary artery bypass grafting; DES: drug-eluding stents; PVD: peripheral vascular disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarct; EF: ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
